Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lincoln, Nebraska 68502


Purpose:

The APD791-002 study is designed primarily to evaluate the safety, tolerability, and pharmacokinetics of APD791 when administered for 7 days to healthy adult subjects.


Criteria:

Inclusion Criteria: - Healthy adult men and women, ages 19-45 - Non smokers Exclusion Criteria: - History of a bleeding disorder - Use of any drug known to have an effect on coagulation or clotting or any anti-platelet therapy within 2 weeks of the screening - Recently donated blood or had significant blood loss - Current use of a prescription medication - Pregnant females


NCT ID:

NCT00619931


Primary Contact:

Principal Investigator
James Kisicki, MD
MDS Pharma Services


Backup Contact:

N/A


Location Contact:

Lincoln, Nebraska 68502
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.